Astoria Portfolio Advisors Llc. Amgen Inc Transaction History

Astoria Portfolio Advisors Llc.

$280 Million
Q3 2024

A detailed history of Astoria Portfolio Advisors Llc. transactions in Amgen Inc stock. As of the latest transaction made, Astoria Portfolio Advisors Llc. holds 2,608 shares of AMGN stock, worth $834,977. This represents 0.3% of its overall portfolio holdings.

Number of Shares

2,608

Previous 2,515 3.7%

Holding current value

$834,977

Previous $785,000 7.01%

% of portfolio

0.3%

Previous 0.29%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $28,772 - $31,376	93 Added 3.7%	2,608 $840,000
Q2 2024 Jul 09, 2024	BUY	$262.75 - $319.31 $525 - $638	2 Added 0.08%	2,515 $785,000
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $2,957 - $3,570	11 Added 0.44%	2,513 $714,000
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $126,571 - $142,787	-495 Reduced 16.52%	2,502 $720,000
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $106,482 - $132,201	-487 Reduced 13.98%	2,997 $805,000
Q2 2023 Jul 14, 2023	BUY	$214.27 - $253.37 $61,281 - $72,463	286 Added 8.94%	3,484 $773,000
Q1 2023 Apr 05, 2023	SELL	$225.79 - $275.2 $6,322 - $7,705	-28 Reduced 0.87%	3,198 $773,000
Q4 2022 Jan 23, 2023	BUY	$229.03 - $291.01 $104,208 - $132,409	455 Added 16.42%	3,226 $0
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $186,301 - $210,114	830 Added 42.76%	2,771 $625,000
Q2 2022 Jul 07, 2022	BUY	$230.71 - $256.74 $78,441 - $87,291	340 Added 21.24%	1,941 $472,000
Q1 2022 Jun 01, 2022	SELL	$219.27 - $242.57 $83,541 - $92,419	-381 Reduced 19.22%	1,601 $387,000
Q4 2021 Jun 01, 2022	BUY	$198.88 - $227.6 $394,180 - $451,103	1,982 New	1,982 $446,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Astoria Portfolio Advisors Llc., based on Form 13F filings with the SEC.

News

Stay updated on Astoria Portfolio Advisors Llc. with notifications on news.

Account

Astoria Portfolio Advisors Llc. Amgen Inc Transaction History